The Global Lacrimal Devices Industry is poised for substantial growth, with a projected market value of US$ 39.7 million by the end of 2029, according to a recent report by Future Market Insights Inc. This impressive growth represents a robust Compound Annual Growth Rate (CAGR) of 5.5%, building upon the industry’s approximate US$ 25.6 million …
Category Archives: Healthcare Trends
Global Radiation Toxicity Treatment Industry Soars, Anticipates a Remarkable 5.8% CAGR, Projected to Reach US$ 5.58 Billion by 2029 | FMI Reports
Future Market Insights (FMI), a renowned market research firm, has released an exhaustive report revealing a substantial growth trajectory for the Global Radiation Toxicity Treatment Industry. The industry, which was valued at US$ 3.76 billion in 2022, is poised for a remarkable upswing, projected to reach an impressive US$ 5.58 billion by 2029. The past …
Global Implantable Drug Eluting Device Industry Poised for 6.0% CAGR Surge, Anticipating a Staggering US$ 19.3 Billion Market by 2029 | FMI
The Global Implantable Drug Eluting Device Industry is on the verge of a groundbreaking transformation, fueled by the latest forecast from Future Market Insights (FMI). Projections indicate a substantial Compound Annual Growth Rate (CAGR) of 6.0% from 2022 to 2029, catapulting the industry beyond the US$ 10 billion milestone by the close of this year. …
Dementia Management Market Targets US$ 75.56 Million by 2033
Witnessing remarkable growth, the global dementia management market trends is poised to reach a significant milestone, projected to soar to US$ 75.56 Million by 2033 from its initial US$ 35 Million value in 2023. This trajectory is underpinned by an impressive compound annual growth rate (CAGR) of 8% throughout the forecast period from 2023 to …
Continue reading “Dementia Management Market Targets US$ 75.56 Million by 2033”
Absorbable Tissue Spacer Market Ascends Toward Projected US$ 303.8 Million Milestone by 2032
Estimates suggest that the absorbable tissue spacer market sale, which was estimated to be worth US$ 80 million in 2018, will expand significantly and surpass US$ 303.8 million by 2032. A prominent source of industry intelligence projects a strong Compound Annual Growth Rate (CAGR) of almost 10% from 2022 to 2032. The increasing incidence of …
Nucleic Acid Isolation Market Positioned to Surpass US$ 1452.9 Million by 2029
The nucleic acid isolation and purification market trends is expected to reach a potential total value of US$ 1452.9 million globally by 2029, with a compound annual growth rate (CAGR) of 5.6% from 2022 to 2029. The global market for nucleic acid isolation and purification is projected to be valued US$ 994.8 million by 2022. …
Continue reading “Nucleic Acid Isolation Market Positioned to Surpass US$ 1452.9 Million by 2029”
Deflectable Catheters Market Aims for US$ 2.4 Billion Valuation by 2029
By 2029, the deflectable catheter market trends is expected to develop at a compound annual growth rate (CAGR) of 3.9% worldwide. By 2029, deflectable catheter sales are expected to reach a market valuation of US$ 2.4 billion, up from the current predicted US$ 1.8 billion. Because deflectable catheters can be used in a wide range …
Continue reading “Deflectable Catheters Market Aims for US$ 2.4 Billion Valuation by 2029”
HIV/HBV/HCV Test Kits Market Sets Sights on US$ 11,573.9 Million by 2033
The HIV/HBV/HCV test kits market sale is projected to generate US$ 11,573,9 million in revenue in 2033 and US$ 6,568.3 million in revenue in 2023. Over the course of the projection year, sales of HIV/HBV/HCV test kits are anticipated to rise at a noteworthy compound annual growth rate (CAGR) of 5.8%. The global incidence of …
Continue reading “HIV/HBV/HCV Test Kits Market Sets Sights on US$ 11,573.9 Million by 2033”
Clinical Oncology Next-generation Sequencing Market Aims for US$ 1.14 Billion Valuation by 2029
The clinical oncology next-generation sequencing market share is expected to reach a value of US$ 449.4 million by 2022. Owing to the increasing application of next-generation sequencing (NGS) in clinical oncology for more effective, individualised cancer treatment, the market is anticipated to grow at an astounding 16.3% CAGR from 2022 to 2029, when it will …
Gene Editing Tools Market: Anticipates Meteoric Rise, Targeting US$ 1.6 Billion Valuation by 2029
The latest analysis from FMI projects that the global gene editing tools market size will generate revenues of more than US$ 481.3 million by 2022. Based on market research, the gene editing tools market is projected to expand at a compound annual growth rate (CAGR) of about 18.8% from 2022 to 2029. The Clustered Regularly …